Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4642 (MIR4642) is a small non-coding RNA molecule classified as a microRNA within the human genome. MicroRNAs are ~22 nucleotides long and regulate gene expression post-transcriptionally by binding to partially complementary sequences on target messenger RNAs, leading to translational repression or mRNA degradation[2][4][5]. The biogenesis of microRNAs involves processing by Drosha and Dicer enzymes, after which the mature miRNA is loaded into the Argonaute (AGO) protein, forming part of the RISC silencing complex[2][4]. While the roles of many microRNAs in development, cancer, apoptosis, and differentiation are established[3][5], there are no specific biological functions, disease associations, or therapeutic targeting described for MIR4642 as of the current literature. MIR4642 may be expressed in various cells and tissues, but detailed functional and pathological roles require further study.
Not applicable. No drugs are known to target MIR4642 directly. Generally, microRNAs mediate gene silencing via RNA-induced silencing complex (RISC) loading and mRNA binding[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4642 (MIR4642).